Quick Summary
Luo Han Guo, also known as monk fruit, is a traditional Chinese medicinal and food plant commonly used as a natural non-caloric sweetener. It contains bioactive compounds such as mogrosides, flavonoids, and triterpenoids, which have been studied for potential antioxidant, anti-inflammatory, and metabolic effects. Traditionally, it has been used to moisten the lungs, relieve cough, and calm asthma. Recent randomized controlled trials (RCTs) in humans suggest that monk fruit extract may reduce postprandial glucose and insulin responses without severe adverse effects. Preclinical studies have explored its possible role in pulmonary fibrosis and diabetic kidney disease, but clinical evidence remains limited, and more research is needed.
What Is It?
Luo Han Guo (Siraitia grosvenorii), commonly known as monk fruit, is a vine native to southern China and northern Thailand. The fruit is valued for its intensely sweet compounds and has a long history of use in traditional Chinese medicine and cuisine. The sweetening component, mogrosides, offers a natural alternative to sugar with minimal calories.
Traditional Uses
In traditional Chinese medicine, Luo Han Guo has been used primarily for respiratory and digestive health. It is employed to moisten the lungs, relieve cough, calm asthma symptoms, and resolve phlegm. It has also been consumed as a herbal tea for general health and wellness. However, robust clinical studies to confirm these traditional uses in humans are lacking.
Active Compounds
- Mogrosides: Potent sweet compounds responsible for the natural sweetness of the fruit.
- Flavonoids: Plant compounds with antioxidant and anti-inflammatory properties.
- Triterpenoids: Bioactive molecules that may contribute to metabolic and inflammatory modulation.
Potential Benefits with Evidence Levels
- Potential Metabolic Health Benefits (Moderate evidence): Human RCTs suggest monk fruit extract may reduce postprandial blood glucose by 10-18% and insulin responses by 12-22% without severe adverse effects reported.
- Anti-inflammatory and Antioxidant Properties (Preclinical/Emerging evidence): Laboratory and network pharmacology studies indicate antioxidant and anti-inflammatory effects, including possible immune-inflammatory pathway modulation relevant to diabetic kidney disease and lung inflammation.
- Anti-pulmonary Fibrosis Potential (Preclinical evidence): Animal and molecular docking studies have identified candidate compounds and pathways (PI3K/AKT and SRC/STAT3) potentially involved in mitigating idiopathic pulmonary fibrosis.
- Traditional Use for Respiratory and Digestive Health (Traditional use / Insufficient clinical evidence): Historically used for lung moistening and cough relief, but clinical trials validating such uses are not available.
Side Effects
Randomized controlled trials have reported no severe adverse effects associated with monk fruit extract consumption. Preclinical studies similarly do not note specific adverse effects. However, there is a lack of long-term safety data, and further studies are required to establish a comprehensive safety profile.
Drug Interactions
Currently, there are no documented drug interaction data available for Luo Han Guo based on the reviewed literature.
Who Should Avoid It
No specific contraindications have been reported in existing research. Due to limited safety data, caution is advised for pregnant or breastfeeding women. People with allergies or sensitivities to related compounds should also exercise caution.
Evidence Limitations
- Limited number of high-quality randomized controlled trials in humans.
- Most pharmacological effects are supported primarily by preclinical evidence.
- Insufficient data on long-term safety, drug interactions, and use in special populations such as pregnant women.
- Traditional uses are not sufficiently supported by robust clinical trial data.
References
- Kaim U, Labus K. Monk Fruit Extract and Sustainable Health: A PRISMA-Guided Systematic Review of Randomized Controlled Trials. Europe PMC. 2025. DOI: 10.3390/nu17091433.
- Cui Q, Liu Y, Li Y, et al. Exploring the potential mechanisms of anti-pulmonary fibrosis effects of Luo Han Guo via network pharmacology, molecular docking, and experimental validation. Europe PMC. 2025. DOI: 10.1038/s41598-025-25270-3.
- Zeng Q, Wang W, Li Y, et al. Beneficial effects of food-medicine homologous herbs for patients with diabetic kidney disease. Europe PMC. 2025. DOI: 10.3389/fimmu.2025.1698240.
- Long T, Hu R, Cheng Z, et al. Ethnobotanical study on herbal tea drinks in Guangxi, China. Europe PMC. 2023. DOI: 10.1186/s13002-023-00579-3.
- Dou T, Wang J, Liu Y, et al. A Combined Transcriptomic and Proteomic Approach to Reveal the Effect of Mogroside V on OVA-Induced Pulmonary Inflammation in Mice. Europe PMC. 2022. DOI: 10.3389/fimmu.2022.800143.
Last Reviewed
2025
Disclaimer
This page provides information based on current scientific evidence and traditional knowledge. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using herbal supplements, especially if you are pregnant, breastfeeding, have underlying health conditions, or are taking other medications.